Cantuzumab is a monoclonal antibody that binds the CanAg antigen, exhibiting anti-tumor properties. It serves as the antibody component of the antibody-drug conjugate cantuzumab mertansine, utilized in cancer research for both in vitro and in vivo experimental studies.
Concentration:
13.1 mg/mL
Molecular Weight:
147.02 kDa
Purity:
99.76% (May vary between batches)
CAS Number:
[1204740-23-7]
Target:
ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted